Suppr超能文献

非人灵长类动物面部亚单位复合组织同种异体移植:I. 延长移植物存活时间的技术和免疫抑制要求。

Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival.

作者信息

Barth Rolf N, Bluebond-Langner Rachel, Nam Arthur, Stanwix Matthew, Shipley Steven, Bartlett Stephen T, Rodriguez Eduardo D

机构信息

Baltimore, Md. From the Division of Transplantation, Department of Surgery; Plastic, Reconstructive, and Maxillofacial Surgery, R Adams Cowley Shock Trauma Center; and Program for Comparative Medicine, University of Maryland School of Medicine.

出版信息

Plast Reconstr Surg. 2009 Feb;123(2):493-501. doi: 10.1097/PRS.0b013e3181954edd.

Abstract

BACKGROUND

Widespread application of composite tissue allotransplantation has been impeded by risks of rejection and conventional immunosuppression. The authors have developed a nonhuman primate composite tissue allotransplantation model that demonstrated reliable and long-term success necessary to progress to preclinical studies.

METHODS

Composite facial subunits (e.g., skin, muscle, and bone) were transplanted between mismatched cynomolgus monkeys. Vascular supply was based on the common carotid artery and external and internal jugular veins. Facial allografts were heterotopically transplanted to the recipient's lower abdomen with end-to-side anastomoses of the common carotid artery to the common femoral artery and of both the internal and external jugular veins to the common femoral vein. Animals received tacrolimus monotherapy. Grafts were inspected daily, submitted to biopsy regularly, and studied with magnetic resonance imaging.

RESULTS

Thirteen transplants were performed. Two grafts based on the common carotid artery and only the internal jugular vein failed within 3 to 5 days because of venous thrombosis not related to rejection. Subsequent transplants included anastomoses of both the internal and external jugular veins to the common femoral vein without thromboses. Immunosuppression consisted of tacrolimus monotherapy and was tolerated without complications. Long-term success was achieved with rejection-free graft survival (60 to 177 days).

CONCLUSIONS

The authors have developed the first successful model of facial composite tissue allotransplantation in a nonhuman primate. Technical requirements include preservation of both internal and external jugular venous outflow. Tacrolimus monotherapy permitted prolonged rejection-free graft survival without early complications. This model provides a platform for further investigation of composite tissue allotransplantation tolerance and requirements for indefinite survival.

摘要

背景

排斥反应风险和传统免疫抑制阻碍了复合组织同种异体移植的广泛应用。作者建立了一种非人灵长类复合组织同种异体移植模型,该模型展现了推进到临床前研究所需的可靠且长期的成功。

方法

在不匹配的食蟹猴之间移植复合面部亚单位(如皮肤、肌肉和骨骼)。血管供应基于颈总动脉以及颈外静脉和颈内静脉。面部同种异体移植物异位移植到受体的下腹部,将颈总动脉与股总动脉进行端侧吻合,颈内静脉和颈外静脉均与股总静脉进行端侧吻合。动物接受他克莫司单一疗法。每天检查移植物,定期进行活检,并采用磁共振成像进行研究。

结果

共进行了13次移植。2例基于颈总动脉且仅吻合颈内静脉的移植物在3至5天内因与排斥反应无关的静脉血栓形成而失败。随后的移植包括将颈内静脉和颈外静脉均与股总静脉进行吻合,未出现血栓形成。免疫抑制采用他克莫司单一疗法,耐受性良好,无并发症。实现了长期成功,移植物无排斥存活(60至177天)。

结论

作者建立了首个成功的非人灵长类面部复合组织同种异体移植模型。技术要求包括保留颈内静脉和颈外静脉的流出道。他克莫司单一疗法使移植物能够长期无排斥存活,且无早期并发症。该模型为进一步研究复合组织同种异体移植耐受性及无限期存活的要求提供了一个平台。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验